New York Stock

'17% Gain' vs. '13% Loss'… Why Anthropic's IPO Debut Brought Mixed Fortunes

IPO Yields 17% Return; 13% Loss If Bought at Opening Price Opened at $111.50 → High of $115.10 → Closed at $97.17 More Than Half of Institutional Subscriptions Ended in Nothing… Over 100 Million Shares Traded on First Day Focus on the Value of Shares Held by Founders and Executives… Distinguished from Cash Proceeds AI Stocks Weak Despite Successful IPOs… “The Next Three Years Will Determine Corporate Value”

Seong Joowon
2026-11-20 06:27:30
[New York = E-Daily Seong Joowon Correspondent] Even though they all held Anthropic stock, some investors posted a 17% gain while others suffered a 13% loss. Anthropic, the developer of the generative AI “Claude,” closed well above its offering price on its first day of trading, but investors who bought at the opening price incurred paper losses. The success of the largest initial public offering (IPO) in history and the returns for floor traders were two separate matters.
Anthropic CEO Dario Amodei, President and Co-founder Daniela Amodei, Co-founder and Chief Scientific Officer (CSO) Jared Kaplan, and Co-founder and Head of Public Interest Jack Clark celebrate the company’s listing at an event marking Anthropic’s initial public offering (IPO) held at the Nasdaq MarketSite in Manhattan, New York, on the 19th (local time). (Photo: Reuters)

On the 19th (local time), Anthropic closed trading on the Nasdaq at $97.17, up 17.07% from its initial public offering (IPO) price of $83. The ticker symbol is “ANT.” According to CNBC, the fully diluted enterprise value based on the closing price was approximately $1.75 trillion (about 2,334.85 trillion won). This figure accounts for the potential conversion of stock options and other equity instruments.
Trading began just before noon. The stock opened at $111.50—34.3% above the IPO price—and rose as high as $115.10 during the session. However, it subsequently fell below $100 and, after fluctuating between gains and losses throughout the afternoon, closed at $97.17. The percentage gain relative to the offering price narrowed from an intraday high of approximately 38.7% to 17.1% at the close.
Results varied depending on the purchase price. Investors who were allocated shares at $83 and held them until the close realized a paper gain of $14.17 per share. In contrast, those who bought at the opening price suffered a paper loss of $14.33 per share, or about 12.9%. Those who bought at the intraday high incurred a loss of approximately 15.6%. Actual gains or losses depend on whether the shares were sold and at what price.
Not everyone had the opportunity to buy at the offering price. According to Bloomberg, while approximately 1,200 institutional investors participated in the subscription, more than half were not allocated a single share. Matt Murphy, a partner at Menlo Ventures, stated that his firm was allocated only about half of the offering volume the company had sought.
On the other hand, large-scale trading took place at the high opening price. Bloomberg reported that the volume traded at the opening price exceeded 100 million shares. For investors who bought at that price and held until the close, the IPO’s success did not immediately translate into profits.
Anthropic logo (Photo: Reuters)

For founders, early investors, and employees, it was the day the market value of their holdings was revealed. Reuters reported that thousands of current and former employees became millionaires on paper as a result of the listing. However, the valuation of their shares does not equate to actual cash proceeds.
Anthropic raised both the offering price and the number of shares sold, resulting in a base offering amount of approximately $81.3 billion. Combined with the $26 billion in private placements, the total transaction size amounted to approximately $107.3 billion. This figure includes shares sold by existing shareholders, so not all of the funds will flow directly into the company.
The successful IPO failed to boost AI-related stocks across the board. Around the time trading in Anthropic began, major indices turned bearish, and all three major New York stock market indices—including the Nasdaq Composite—closed down more than 2%. Analysts attributed this to a combination of capital shifts from other stocks into Anthropic, profit-taking, and caution regarding the profitability of AI investments.
Zed Ellerbrook, a portfolio manager at Agent Capital, told Reuters, “Investors are adjusting their portfolios to include Anthropic,” adding that he would not read too much into the day’s movements.
After the first day, performance will be key. Ted Mortenson, a technology strategist at Baird, told CNBC, “How the company navigates the next three years will determine its enterprise value.” The next test will be whether it can translate the success of its IPO into sustained revenue and profits.
On the 19th (local time), a protest against the initial public offering (IPO) of artificial intelligence (AI) company Anthropic took place in front of the Nasdaq MarketSite in Manhattan, New York. Anthropic went public on the Nasdaq that day. (Photo: Reuters)

Economy

Corporation

IT·Science

Economy

BlackRock: "Tokenization Offers Greater Growth Opportunities Than Virtual Asset ETFs"

BlackRock, the world’s largest asset manager, forecasts additional growth opportunities in the Bitcoin and cryptocurrency investment product markets. However, the firm predicts that tokenization will …
2026-11-20 07:31:12

Corporation

"Muscle Is an Asset, Too"... SamyangFoods Promotes 'Spindle' with So Ji-sub as the Face of the Campaign

SamyangFoods has launched a campaign to promote its healthcare brand “Spindle” featuring actor So Ji-sub. The company has released an advertisement that likens strength training to financial investmen…
2026-11-20 08:35:31

IT·Science

Celltrion Wins Consecutive Hospital Tenders in Belgium and Germany… Accelerating Sales Expansion in Europe

(Graphic: ChatGPT) Celltrion(068270)’s European subsidiaries have secured supply contracts one after another in procurement tenders conducted by local hospitals and pharmaceutical purchasing organ…
2026-11-20 07:32:02